Federation des caisses Desjardins du Quebec’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-75	Closed	-$1.51K	–	2641
2021 Q3	$1.51K	Hold	75	–	–	﹤0.01%	2428
2021 Q2	$2.8K	Buy	+75	New	+$2.3K	﹤0.01%	2362

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's DRNA Position: Q4 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 75 shares — an estimated $1.51K sold.

Federation des caisses Desjardins du Quebec first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $2.8K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Federation des caisses Desjardins du Quebec reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 75 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.51K.
Federation des caisses Desjardins du Quebec first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Federation des caisses Desjardins du Quebec's Dicerna Pharmaceuticals, Inc. position peaked at $2.8K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2021, filed 30 Aug 2024.